Polaris Venture Management Co V’s X4 Pharmaceuticals XFOR Stock Holding History

Polaris Venture Management Co V’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.65M	Hold	10,383	–	–	11.7%	2
2021 Q2	$2.02M	Hold	10,383	–	–	3.24%	3
2021 Q1	$2.68M	Hold	10,383	–	–	3.48%	4
2020 Q4	$2M	Hold	10,383	–	–	2.61%	4
2020 Q3	$2.11M	Hold	10,383	–	–	3.48%	5
2020 Q2	$2.9M	Hold	10,383	–	–	2.26%	5
2020 Q1	$3.12M	Hold	10,383	–	–	2.82%	5
2019 Q4	$3.33M	Hold	10,383	–	–	2.42%	5
2019 Q3	$3.96M	Hold	10,383	–	–	2.25%	7
2019 Q2	$4.67M	Hold	10,383	–	–	3.67%	6
2019 Q1	$5.42M	Hold	10,383	–	–	4.59%	6
2018 Q4	$4.34M	Hold	10,383	–	–	4.63%	6
2018 Q3	$3.03M	Hold	10,383	–	–	1.52%	8
2018 Q2	$6.78M	Hold	10,383	–	–	3.7%	7
2018 Q1	$42.8M	Hold	10,383	–	–	24.39%	1
2017 Q4	$23.8M	Buy	+10,383	New	+$26.3M	21.03%	2

Other funds holding XFOR

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Polaris Venture Management Co V's XFOR Position: Q3 2021 in Review

Polaris Venture Management Co V held its X4 Pharmaceuticals (XFOR) position steady in Q3 2021 at 10,383 shares worth $1.65M. The position accounts for 11.7% of the portfolio, ranked #2.

Polaris Venture Management Co V first reported a position in XFOR in Q4 2017 and has held it in 16 quarters since. The position peaked at $42.8M in Q1 2018. 51 funds tracked by Wall St. Rank hold XFOR as of Q3 2021.

Polaris Venture Management Co V held 10,383 shares of X4 Pharmaceuticals worth $1.65M as of Q3 2021.
Polaris Venture Management Co V left its X4 Pharmaceuticals share count unchanged in Q3 2021.
X4 Pharmaceuticals made up 11.7% of Polaris Venture Management Co V's portfolio in Q3 2021, its #2 holding.
Polaris Venture Management Co V first reported a position in X4 Pharmaceuticals in Q4 2017 and has held it in 16 quarters since.
Polaris Venture Management Co V's X4 Pharmaceuticals position peaked at $42.8M in Q1 2018.
51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2021.

Based on Polaris Venture Management Co V's 13F filing for Q3 2021, filed 12 Nov 2021.